Category Archives: Medicine

EpiPen Pricing Defended by Shkreli

Martin Shkreli, pharmaceutical patent scavenger, did an interview with CBS and defended Mylan Corp’s inflated pricing of their EpiPen product. “This particular drug is a necessity for some people,” Nair said. “Yeah sure, that’s great – but I think important medicine should be expensive because they’re valuable,” said Martin Shkreli. The former pharmaceutical chief gained… Read More »

The Worms Turn… and a Patient Recovers

A CNN report describes a motivated ulcerative colitis patient arranging for his own experimental treatment. Experimenting on yourself is frowned upon, but that patient persevered and is doing better. Meanwhile, the patient had gone on the internet and found an article in a medical journal by Dr. Joel Weinstock, chief of gastroenterology at Tufts University… Read More »

Health Care in the News

There was a piece on NPR about balancing the budget and how Medicare alone is 12% of the federal budget, or $500B dollars. $500B dollars… that works out to about $16,000 dollars per US citizen per year. [I apparently entered an extra 0 plugging that into the calculator, which brings the calculated figure down to… Read More »

Comment on Swank Antievolution

I left a comment to the opinion letter of a Greg Swank, M.D.. Dr. Swank gave a Gish Gallop and finished up with argument from authority. My background is in the medical field and I find it interesting that from a science background I am defending Intelligent Design as a scientific probability, while Rev. Ward… Read More »

CoverFlorida Health Care

Last year, the CoverFlorida Health Care program got started. This is essentially group insurance for the Florida uninsured pool, organized by (but not paid for by) the state of Florida. Governor Charlie Crist says the following on the CoverFlorida website: During the 2008 legislative session, my administration worked with legislators of both parties to secure… Read More »

Medical and Journalistic Shading

Marcia Angell has an article in the New York Review of Books that considers three books touching upon modern medicine and unseemly links to corporate pharmaceutical companies. Angell takes up various problems, but I was intrigued when she got around to how companies now control research, sometimes shading a negative experimental result in a way… Read More »